In December 2025, pimicotinib was approved by the China National Medical Products Administration (NMPA) for the treatment of adult patients with symptomatic TGCT for which surgical resection will ...
Developers have a growing array of options for AI-powered low-code and no-code development tools. But using them to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback